This inventor holds 1 USPTO granted patent. Top assignee: Nektar Therapeutics. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Christopher Frantz: Innovator in Amphotericin B Compositions
Introduction
Christopher Frantz is a notable inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on amphotericin B. His innovative work has led to the development of a unique composition that has potential applications in medical treatments.
Latest Patents
Frantz holds a patent for "Compositions comprising amphotericin B, methods, and systems." This patent describes a composition that includes particles containing at least about 95 wt % of amphotericin B. The particles have a mass median diameter ranging from about 1.1 μm to about 1.9 μm. Additionally, another composition includes particles where at least about 80 wt % have a geometric diameter within the same range. Furthermore, the patent details compositions where the particles have a mass median diameter of less than about 1.9 μm, with the amphotericin B exhibiting a crystallinity level of at least about 20%. These compositions may be utilized in unit dosage forms, delivery systems, and various methods.
Career Highlights
Christopher Frantz is currently associated with Nektar Therapeutics, where he continues to advance his research and development efforts. His work at Nektar Therapeutics has positioned him as a key player in the pharmaceutical industry, particularly in the area of drug formulation and delivery.
Collaborations
Frantz collaborates with esteemed colleagues such as Sarma Duddu and Srinivas Palakodaty. Their combined expertise contributes to the innovative projects at Nektar Therapeutics, enhancing the potential for groundbreaking advancements in drug delivery systems.
Conclusion
Christopher Frantz is a distinguished inventor whose work on amphotericin B compositions showcases his commitment to innovation in the pharmaceutical field. His contributions have the potential to significantly impact medical treatments and improve patient outcomes.